Compare TFX & GNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFX | GNTX |
|---|---|---|
| Founded | 1943 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.0B |
| IPO Year | 1994 | 1995 |
| Metric | TFX | GNTX |
|---|---|---|
| Price | $134.51 | $23.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $138.75 | $26.60 |
| AVG Volume (30 Days) | 865.1K | ★ 2.1M |
| Earning Date | 05-07-2026 | 04-24-2026 |
| Dividend Yield | 1.02% | ★ 2.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | $1,992,713,000.00 | ★ $2,534,268,965.00 |
| Revenue This Year | $15.97 | $6.89 |
| Revenue Next Year | $5.15 | $4.58 |
| P/E Ratio | ★ N/A | $49.32 |
| Revenue Growth | N/A | ★ 9.55 |
| 52 Week Low | $100.18 | $20.48 |
| 52 Week High | $139.67 | $29.38 |
| Indicator | TFX | GNTX |
|---|---|---|
| Relative Strength Index (RSI) | 61.31 | 51.70 |
| Support Level | $102.20 | $22.49 |
| Resistance Level | $134.84 | $23.70 |
| Average True Range (ATR) | 4.18 | 0.51 |
| MACD | 0.08 | -0.07 |
| Stochastic Oscillator | 91.23 | 47.92 |
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion, with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.